{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T17:04:37Z","timestamp":1772643877728,"version":"3.50.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11910-018-0907-6","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T06:34:01Z","timestamp":1539585241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Interaction Between Neuropsychiatric Symptoms and Cognitive Performance in Parkinson\u2019s Disease: What Do Clinical and Neuroimaging Studies Tell Us?"],"prefix":"10.1007","volume":"18","author":[{"given":"Alexandru","family":"Hanganu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oury","family":"Monchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,15]]},"reference":[{"key":"907_CR1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","volume":"72","author":"S-M Fereshtehnejad","year":"2015","unstructured":"\u2022\u2022 Fereshtehnejad S-M, Romenets SR, Anang JBM, Latreille V, Gagnon J-F, Postuma RB. New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol. 2015;72:863\u201373 The first study to define clinical subtypes of PD according to their evolution.","journal-title":"JAMA Neurol"},{"issue":"8","key":"907_CR2","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1212\/01.wnl.0000180516.69442.95","volume":"65","author":"D Muslimovic","year":"2005","unstructured":"Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology. 2005;65(8):1239\u201345.","journal-title":"Neurology"},{"issue":"13","key":"907_CR3","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/01.wnl.0000338632.00552.cb","volume":"72","author":"D Aarsland","year":"2009","unstructured":"Aarsland D, Br\u00f8nnick K, Larsen JP, Tysnes OB, Alves G. Cognitive impairment in incident, untreated parkinson disease: the norwegian parkwest study. Neurology. 2009;72(13):1121\u20136.","journal-title":"Neurology."},{"key":"907_CR4","unstructured":"Litvan I, Goldman JG, Tr\u00f6ster AI, Schmand BA, Weintraub D, Petersen RC, et al. Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society Task Force guidelines. Mov Disord. Wiley Online Library. 2012;27:349\u201356."},{"issue":"3","key":"907_CR5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"K Ray Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AH V. Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol. Elsevier. 2006;5:235\u201345.","journal-title":"The Lancet Neurology"},{"issue":"1","key":"907_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2010.08.012","volume":"17","author":"S-E Soh","year":"2011","unstructured":"Soh S-E, Morris ME, McGinley JL. Determinants of health-related quality of life in Parkinson\u2019s disease: a systematic review. Parkinsonism Relat Disord. 2011;17(1):1\u20139.","journal-title":"Parkinsonism Relat Disord."},{"issue":"15","key":"907_CR7","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/mds.23394","volume":"25","author":"DA Gallagher","year":"2010","unstructured":"Gallagher DA, Lees AJ, Schrag A. What are the most important nonmotor symptoms in patients with Parkinson\u2019s disease and are we missing them? Mov Disord. 2010;25(15):2493\u2013500.","journal-title":"Mov Disord."},{"issue":"4","key":"907_CR8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jnnp.67.4.492","volume":"67","author":"D. Aarsland","year":"1999","unstructured":"Aarsland D, Larsen JP, Lim NG, Janvin C, Karlsen K, Tandberg E, et al. Range of neuropsychiatric disturbances in patients with Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. BMJ Publishing Group Ltd. 1999;67:492\u20136.","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"8","key":"907_CR9","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/jnnp.2008.166959","volume":"80","author":"D Aarsland","year":"2009","unstructured":"Aarsland D, Br\u00f8nnick K, Alves G, Tysnes OB, Pedersen KF, Ehrt U, et al. The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2009;80(8):928\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"907_CR10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3233\/JAD-150869","volume":"50","author":"T Nagata","year":"2016","unstructured":"Nagata T, Shinagawa S, Nakajima S, Plitman E, Mihashi Y, Hayashi S, et al. Classification of neuropsychiatric symptoms requiring antipsychotic Treatment in patients with Alzheimer\u2019s Disease: analysis of the CATIE-AD Study. J Alzheimer\u2019s Dis. 2016;50(3):839\u201345.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"5","key":"907_CR11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","volume":"8","author":"K Ray Chaudhuri","year":"2009","unstructured":"Chaudhuri KR, Schapira AH V. Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment. Lancet Neurol. Elsevier. 2009;8:464\u201374.","journal-title":"The Lancet Neurology"},{"issue":"3","key":"907_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jagp.2016.10.004","volume":"25","author":"Eva Pirogovsky-Turk","year":"2017","unstructured":"\u2022\u2022 Pirogovsky-Turk E, Moore RC, Filoteo JV, Litvan I, Song DD, Lessig SL, et al. Neuropsychiatric predictors of cognitive decline in Parkinson disease: a longitudinal study. Am J Geriatr Psychiatry [Internet]. Elsevier. 2017;25:279\u201389. Available from: https:\/\/doi.org\/10.1016\/j.jagp.2016.10.004 . One of the first studies to describe the relationship between neuropsychiatric symptoms and cognitive decline in Parkinson\u2019s disease longitudinally.","journal-title":"The American Journal of Geriatric Psychiatry"},{"key":"907_CR13","doi-asserted-by":"crossref","unstructured":"Ye BS, Jeon S, Yoon S, Kang SW, Baik K, Lee Y, et al. Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. BMJ Publishing Group Ltd. 2017;jnnp-2017.","DOI":"10.1136\/jnnp-2017-316075"},{"issue":"1","key":"907_CR14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mds.21765","volume":"23","author":"Adam Feldmann","year":"2008","unstructured":"Feldmann A, Illes Z, Kosztolanyi P, Illes E, Mike A, Kover F, et al. Morphometric changes of gray matter in Parkinson\u2019s disease with depression: a voxel-based morphometry study. Mov Disord. Wiley Online Library. 2008;23:42\u20136.","journal-title":"Movement Disorders"},{"issue":"8","key":"907_CR15","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.parkreldis.2014.04.027","volume":"20","author":"C. O'Callaghan","year":"2014","unstructured":"O\u2019Callaghan C, Shine JM, Lewis SJG, Hornberger M. Neuropsychiatric symptoms in Parkinson\u2019s disease: fronto-striatal atrophy contributions. Parkinsonism Relat Disord. Elsevier. 2014;20:867\u201372.","journal-title":"Parkinsonism & Related Disorders"},{"key":"907_CR16","unstructured":"Van Rooden SM, Visser M, Verbaan D, Marinus J, Van Hilten JJ. Patterns of motor Parkinson\u2019s disease: frontodisease. J Neurol Neurosurg Psychiatry. BMJ Publishing Group Ltd; 2009;80:846\u201350."},{"issue":"9","key":"907_CR17","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/mds.20216","volume":"19","author":"Peter Hobson","year":"2004","unstructured":"Hobson P, Meara J. Risk and incidence of dementia in a cohort of older subjects with Parkinson\u2019s disease in the United Kingdom. Mov Disord. Wiley Online Library; 2004;19:1043\u20139.","journal-title":"Movement Disorders"},{"issue":"5","key":"907_CR18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000100850","volume":"23","author":"B Ramirez-Ruiz","year":"2007","unstructured":"Ramirez-Ruiz B, Junque C, Marti M-J, Valldeoriola F, Tolosa E. Cognitive changes in Parkinson\u2019s disease patients with visual hallucinations. Dement Geriatr Cogn Disord. 2007;23(5):281\u20138.","journal-title":"Dement Geriatr Cogn Disord."},{"issue":"1","key":"907_CR19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.26432","volume":"31","author":"Javier Pagonabarraga","year":"2015","unstructured":"Pagonabarraga J, Martinez-Horta S, Fern\u00e1ndez de Bobadilla R, P\u00e9rez J, Ribosa-Nogu\u00e9 R, Mar\u00edn J, et al. Minor hallucinations occur in drug-naive Parkinson\u2019s disease patients, even from the premotor phase. Mov Disord. Wiley Online Library; 2016;31:45\u201352.","journal-title":"Movement Disorders"},{"key":"907_CR20","first-page":"996","volume":"67","author":"EB Forsaa","year":"2010","unstructured":"Forsaa EB, Larsen JP, Wentzel-Larsen T, Goetz CG, Stebbins GT, Aarsland D, et al. A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol. American Medical Association. 2010;67:996\u20131001.","journal-title":"American Medical Association"},{"issue":"1","key":"907_CR21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/mds.25554","volume":"29","author":"Christopher G. Goetz","year":"2013","unstructured":"Goetz CG, Vaughan CL, Goldman JG, Stebbins GT. I finally see what you see: Parkinson\u2019s disease visual hallucinations captured with functional neuroimaging. Mov Disord. Wiley Online Library; 2014;29:115\u20137.","journal-title":"Movement Disorders"},{"issue":"6","key":"907_CR22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/jnnp.70.6.727","volume":"70","author":"J Barnes","year":"2001","unstructured":"Barnes J, David AS. Visual hallucinations in Parkinson\u2019s disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry. BMJ Publishing Group Ltd; 2001;70:727\u201333.","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"14","key":"907_CR23","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/mds.22702","volume":"24","author":"Francesco Roselli","year":"2009","unstructured":"Roselli F, Pisciotta NM, Perneczky R, Pennelli M, Aniello MS, De Caro MF, et al. Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: A 123I-FP-CIT SPECT study. Mov Disord. Wiley Online Library; 2009;24:2097\u2013103.","journal-title":"Movement Disorders"},{"key":"907_CR24","doi-asserted-by":"crossref","unstructured":"Firbank MJ, Parikh J, Murphy N, Killen A, Allan CL, Collerton D, et al. Reduced occipital GABA in Parkinson disease with visual hallucinations. Neurology. AAN Enterprises. 2018:10\u20131212.","DOI":"10.1212\/WNL.0000000000006007"},{"issue":"3","key":"907_CR25","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","volume":"158","author":"Shitij Kapur","year":"2001","unstructured":"Kapur S, Seeman P. Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry. Am Psychiatric Assoc; 2001;158:360\u20139.","journal-title":"American Journal of Psychiatry"},{"key":"907_CR26","first-page":"416","volume":"67","author":"B Ballanger","year":"2010","unstructured":"Ballanger B, Strafella AP, van Eimeren T, Zurowski M, Rusjan PM, Houle S, et al. Serotonin 2A receptors and visual hallucinations in Parkinson disease. Arch Neurol. American Medical Association. 2010;67:416\u201321.","journal-title":"American Medical Association"},{"issue":"7","key":"907_CR27","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1468-1331.2007.01768.x","volume":"14","author":"B. Ram\u00edrez-Ruiz","year":"2007","unstructured":"Ram\u00edrez-Ruiz B, Mart\u00ed M, Tolosa E, Gimenez M, Bargallo N, Valldeoriola F, et al. Cerebral atrophy in Parkinson\u2019s disease patients with visual hallucinations. Eur J Neurol. Wiley Online Library; 2007;14:750\u20136.","journal-title":"European Journal of Neurology"},{"issue":"3","key":"907_CR28","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1176\/jnp.2006.18.3.402","volume":"18","author":"S. Holroyd","year":"2006","unstructured":"Holroyd S, Wooten GF. Preliminary FMRI evidence of visual system dysfunction in Parkinson\u2019s disease patients with visual hallucinations. J Neuropsychiatry Clin Neurosci. Am Neuropsych Assoc; 2006;18:402\u20134.","journal-title":"Journal of Neuropsychiatry"},{"issue":"8","key":"907_CR29","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1212\/01.WNL.0000141853.27081.BD","volume":"63","author":"G. T. Stebbins","year":"2004","unstructured":"Stebbins GT, Goetz CG, Carrillo MC, Bangen KJ, Turner DA, Glover GH, et al. Altered cortical visual processing in PD with hallucinations An fMRI study. Neurology. AAN Enterprises; 2004;63:1409\u201316.","journal-title":"Neurology"},{"issue":"3","key":"907_CR30","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/mds.21923","volume":"23","author":"Hiroshi Kataoka","year":"2008","unstructured":"Kataoka H, Furiya Y, Morikawa M, Ueno S, Inoue M. Increased temporal blood flow associated with visual hallucinations in Parkinson\u2019s disease with dementia. Mov Disord Off J Mov Disord Soc. Wiley Online Library; 2008;23:464\u20135.","journal-title":"Movement Disorders"},{"issue":"7","key":"907_CR31","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/mds.20129","volume":"19","author":"Atsuko Nagano-Saito","year":"2004","unstructured":"Nagano-Saito A, Washimi Y, Arahata Y, Iwai K, Kawatsu S, Ito K, et al. Visual hallucination in Parkinson\u2019s disease with FDG PET. Mov Disord. Wiley Online Library; 2004;19:801\u20136.","journal-title":"Movement Disorders"},{"key":"907_CR32","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/mds.25541","volume":"28","author":"A Hanganu","year":"2013","unstructured":"Hanganu A, Bedetti C, Jubault T, Gagnon J-F, Mejia-Constain B, Degroot C, et al. Mild cognitive impairment in patients with Parkinson\u2019s disease is associated with increased cortical degeneration. Mov Disord. 2013;28:1360\u20139.","journal-title":"Mov Disord."},{"issue":"12","key":"907_CR33","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/mds.25982","volume":"29","author":"B\u00e0rbara Segura","year":"2014","unstructured":"Segura B, Baggio HC, Marti MJ, Valldeoriola F, Compta Y, Garcia-Diaz AI, et al. Cortical thinning associated with mild cognitive impairment in Parkinson\u2019s disease. Mov Disord. Wiley Online Library; 2014;29:1495\u2013503.","journal-title":"Movement Disorders"},{"key":"907_CR34","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/brain\/awu036","volume":"137","author":"A Hanganu","year":"2014","unstructured":"Hanganu A, Bedetti C, Degroot C, Mejia-Constain B, Lafontaine A-L, Soland V, et al. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson\u2019s disease longitudinally. Brain. 2014;137:1120\u20139.","journal-title":"Brain."},{"issue":"10","key":"907_CR35","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1093\/brain\/awv211","volume":"138","author":"Elijah Mak","year":"2015","unstructured":"Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, et al. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study. Brain. Oxford University Press; 2015;138:2974\u201386.","journal-title":"Brain"},{"issue":"Pt 4","key":"907_CR36","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/brain\/awh088","volume":"127","author":"EJ Burton","year":"2004","unstructured":"Burton EJ, McKeith IG, Burn DJ, Williams ED, O\u2019Brien JT. Cerebral atrophy in Parkinson\u2019s disease with and without dementia: a comparison with Alzheimer\u2019s disease, dementia with Lewy bodies and controls. Brain. 2004;127(Pt 4):791\u2013800.","journal-title":"Brain."},{"issue":"3","key":"907_CR37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1034\/j.1600-0447.2002.02229.x","volume":"106","author":"FM Nilsson","year":"2002","unstructured":"Nilsson FM, Kessing LV, Sorensen TM, Andersen PK, Bolwig TG. Major depressive disorder in Parkinson\u2019s disease: a register-based study. Acta Psychiatr Scand. 2002;106(3):202\u201311.","journal-title":"Acta Psychiatr Scand."},{"issue":"2","key":"907_CR38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/mds.21803","volume":"23","author":"JSAM Reijnders","year":"2008","unstructured":"Reijnders JSAM, Ehrt U, Weber WEJ, Aarsland D, Leentjens AFG. A systematic review of prevalence studies of depression in Parkinson\u2019s disease. Mov Disord. 2008;23(2):183\u20139.","journal-title":"Mov Disord"},{"key":"907_CR39","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders (DSM-5\u00ae)","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5\u00ae). Washington, D.C.: American Psychiatric Pub; 2013."},{"issue":"2","key":"907_CR40","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/mds.20723","volume":"21","author":"Laura Marsh","year":"2006","unstructured":"Marsh L, McDonald WM, Cummings J, Ravina B, Disease NWG on D and P. Provisional diagnostic criteria for depression in Parkinson\u2019s disease: report of an NINDS\/NIMH Work Group. Mov Disord. Wiley Online Library; 2006;21:148\u201358.","journal-title":"Movement Disorders"},{"issue":"1","key":"907_CR41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00213-010-1867-y","volume":"211","author":"Andre C. Felicio","year":"2010","unstructured":"Felicio AC, Moriyama TS, Godeiro-Junior C, Shih MC, Hoexter MQ, Borges V, et al. Higher dopamine transporter density in Parkinson\u2019s disease patients with depression. Psychopharmacology (Berl). Springer; 2010;211:27\u201331.","journal-title":"Psychopharmacology"},{"issue":"9","key":"907_CR42","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1093\/brain\/aww162","volume":"139","author":"Audrey Maillet","year":"2016","unstructured":"\u2022\u2022 Maillet A, Krack P, Lhomm\u00e9e E, M\u00e9t\u00e9reau E, Klinger H, Favre E, et al. The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson\u2019s disease. Brain. Oxford University Press; 2016;139:2486\u2013502. The first study to study the effect of apathy in PD on serotonin and dopamine in PD.","journal-title":"Brain"},{"issue":"8","key":"907_CR43","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1001\/archneur.1997.00550200046009","volume":"54","author":"G. Kuzis","year":"1997","unstructured":"Kuzis G, Sabe L, Tiberti C, Leiguarda R, Starkstein SE. Cognitive functions in major depression and Parkinson disease. Arch Neurol. 1997;54(8):982-986","journal-title":"Archives of Neurology"},{"issue":"7","key":"907_CR44","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00415-010-5465-z","volume":"257","author":"O Riedel","year":"2010","unstructured":"Riedel O, Klotsche J, Spottke A, Deuschl G, F\u00f6rstl H, Henn F, et al. Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson\u2019s disease. J Neurol. 2010;257(7):1073\u201382.","journal-title":"J Neurol."},{"issue":"6","key":"907_CR45","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(18)30127-3","volume":"17","author":"Johan Marinus","year":"2018","unstructured":"Marinus J, Zhu K, Marras C, Aarsland D, van Hilten JJ. Risk factors for non-motor symptoms in Parkinson\u2019s disease. Lancet Neurol. Elsevier; 2018;17(6):559-568","journal-title":"The Lancet Neurology"},{"key":"907_CR46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bandc.2016.11.001","volume":"111","author":"Alexandru Hanganu","year":"2017","unstructured":"\u2022 Hanganu A, Bruneau M-A, Degroot C, Bedetti C, Mejia-Constain B, Lafontaine A-L, et al. Depressive symptoms in Parkinson\u2019s disease correlate with cortical atrophy over time. Brain Cogn. Elsevier; 2017;111:127\u201333. The first study to describe the influence of depression on brain\u2019s structure and it\u2019s association with cognitive decline.","journal-title":"Brain and Cognition"},{"issue":"2-3","key":"907_CR47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000489311","volume":"18","author":"Jeong-Yoon Lee","year":"2018","unstructured":"Lee J-Y, Kim JS, Jang W, Park J, Oh E, Youn J, et al. Association between white matter lesions and non-motor symptoms in Parkinson disease. Neurodegener Dis [Internet]. 2018;18:127\u201332. Available from: https:\/\/www.karger.com\/DOI\/10.1159\/000489311","journal-title":"Neurodegenerative Diseases"},{"issue":"10","key":"907_CR48","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.0b013e3181f11c1d","volume":"75","author":"V. S. Kostic","year":"2010","unstructured":"Kosti\u0107 VS, Agosta F, Petrovi\u0107 I, Galantucci S, \u0160pica V, Je\u010dmenica-Lukic M, et al. Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology. AAN Enterprises; 2010;75:857\u201363.","journal-title":"Neurology"},{"issue":"14","key":"907_CR49","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/mds.23268","volume":"25","author":"Jennifer S.A.M. Reijnders","year":"2010","unstructured":"Reijnders JSAM, Scholtissen B, Weber WEJ, Aalten P, Verhey FRJ, Leentjens AFG. Neuroanatomical correlates of apathy in Parkinson\u2019s disease: a magnetic resonance imaging study using voxel-based morphometry. Mov Disord. Wiley Online Library; 2010;25:2318\u201325.","journal-title":"Movement Disorders"},{"issue":"1-2","key":"907_CR50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jns.2015.06.037","volume":"356","author":"Hamad Alzahrani","year":"2015","unstructured":"Alzahrani H, Venneri A. Cognitive and neuroanatomical correlates of neuropsychiatric symptoms in Parkinson\u2019s disease: a systematic review. J Neurol Sci. Elsevier; 2015;356:32\u201344.","journal-title":"Journal of the Neurological Sciences"},{"issue":"9","key":"907_CR51","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.parkreldis.2015.06.014","volume":"21","author":"Aloysius Ng","year":"2015","unstructured":"Ng A, Chander RJ, Tan LCS, Kandiah N. Influence of depression in mild Parkinson\u2019s disease on longitudinal motor and cognitive function. Parkinsonism Relat Disord. Elsevier; 2015;21:1056\u201360.","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1-2","key":"907_CR52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jns.2006.05.031","volume":"248","author":"E Stefanova","year":"2006","unstructured":"Stefanova E, Potrebic A, Ziropadja L, Maric J, Ribaric I, Kostic VS. Depression predicts the pattern of cognitive impairment in early Parkinson\u2019s disease. J Neurol Sci. 2006;248(1-2):131\u20137.","journal-title":"J Neurol Sci"},{"key":"907_CR53","doi-asserted-by":"crossref","unstructured":"Kadhim S, Pringsheim T, Le A, Fiest KM, Patten SB, Prisnie JC, et al. Validating screening tools for depression in Parkinson\u2019s disease. Mov Disord. Wiley Online Library. 2018.","DOI":"10.1002\/mds.27371"},{"issue":"7","key":"907_CR54","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/cercor\/bhj043","volume":"16","author":"Richard Levy","year":"2005","unstructured":"Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex\u2013basal ganglia circuits. Cereb Cortex. Oxford University Press. 2005;16:916\u201328.","journal-title":"Cerebral Cortex"},{"issue":"6","key":"907_CR55","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/mds.26208","volume":"30","author":"Melina G.H.E. den Brok","year":"2015","unstructured":"den Brok MGHE, van Dalen JW, van Gool WA, Moll van Charante EP, de Bie R, Richard E. Apathy in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord. Wiley Online Library. 2015;30:759\u201369.","journal-title":"Movement Disorders"},{"issue":"5","key":"907_CR56","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.parkreldis.2015.02.015","volume":"21","author":"Gabriella Santangelo","year":"2015","unstructured":"Santangelo G, Vitale C, Picillo M, Cuoco S, Moccia M, Pezzella D, et al. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson\u2019s disease patients. Parkinsonism Relat Disord. Elsevier. 2015;21:489\u201393.","journal-title":"Parkinsonism & Related Disorders"},{"issue":"16","key":"907_CR57","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/mds.22843","volume":"24","author":"Kathy Dujardin","year":"2009","unstructured":"Dujardin K, Sockeel P, Delliaux M, Dest\u00e9e A, Defebvre L. Apathy may herald cognitive decline and dementia in Parkinson\u2019s disease. Mov Disord. Wiley Online Library. 2009;24:2391\u20137.","journal-title":"Movement Disorders"},{"issue":"7","key":"907_CR58","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.parkreldis.2012.03.008","volume":"18","author":"Ian Surdhar","year":"2012","unstructured":"Surdhar I, Gee M, Bouchard T, Coupland N, Malykhin N, Camicioli R. Intact limbic-prefrontal connections and reduced amygdala volumes in Parkinson\u2019s disease with mild depressive symptoms. Parkinsonism Relat Disord. Elsevier. 2012;18:809\u201313.","journal-title":"Parkinsonism & Related Disorders"},{"key":"907_CR59","unstructured":"Yan H, Onoda K, Yamaguchi S. Gray matter volume changes in the apathetic elderly. Front Hum Neurosci. Frontiers. 2015;9:318."},{"key":"907_CR60","unstructured":"Remy P, Doder M, Lees A, Turjanski N, Brooks D. Depression in Parkinson\u2019s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain. Oxford University Press. 2005;128:1314\u201322."},{"issue":"8","key":"907_CR61","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.parkreldis.2015.06.009","volume":"21","author":"W Fitts","year":"2015","unstructured":"Fitts W, Weintraub D, Massimo L, Chahine L, Chen-Plotkin A, Duda JE, et al. Caregiver report of apathy predicts dementia in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2015;21(8):992\u20135.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"907_CR62","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hbm.22622","volume":"36","author":"HC Baggio","year":"2015","unstructured":"Baggio HC, Segura B, Sala-Llonch R, Marti MJ, Valldeoriola F, Compta Y, et al. Cognitive impairment and resting-state network connectivity in Parkinson\u2019s disease. Hum Brain Mapp. 2015;36(1):199\u2013212.","journal-title":"Hum Brain Mapp"},{"issue":"5","key":"907_CR63","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/mds.26137","volume":"30","author":"Hugo Cesar Baggio","year":"2015","unstructured":"\u2022 Baggio HC, Segura B, Garrido-Millan JL, Marti M, Compta Y, Valldeoriola F, et al. Resting-state frontostriatal functional connectivity in Parkinson\u2019s disease\u2013related apathy. Mov Disord. Wiley Online Library. 2015;30:671\u20139. The first study to report the influence of apathy on the brain\u2019s functional state in patients with Parkinson\u2019s disease.","journal-title":"Movement Disorders"},{"key":"907_CR64","unstructured":"Hatz F, Meyer A, Zimmermann R, Gschwandtner U, Fuhr P. Apathy in patients with Parkinson\u2019s disease correlates with alteration of left fronto-polar electroencephalographic connectivity. Front Aging Neurosci. Frontiers. 2017;9:262."},{"issue":"3","key":"907_CR65","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1523\/JNEUROSCI.4860-03.2004","volume":"24","author":"O Monchi","year":"2004","unstructured":"Monchi O, Petrides M, Doyon J, Postuma RB, Worsley K, Dagher A. Neural bases of set-shifting deficits in Parkinson\u2019s disease. J Neurosci. 2004;24(3):702\u201310.","journal-title":"J Neurosci"},{"issue":"14","key":"907_CR66","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1523\/JNEUROSCI.3921-07.2008","volume":"28","author":"A Nagano-Saito","year":"2008","unstructured":"Nagano-Saito A, Leyton M, Monchi O, Goldberg YK, He Y, Dagher A. Dopamine depletion impairs frontostriatal functional connectivity during a set-shifting task. J Neurosci. 2008;28(14):3697\u2013706.","journal-title":"J Neurosci"},{"issue":"9","key":"907_CR67","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.parkreldis.2012.05.022","volume":"18","author":"Roberto Erro","year":"2012","unstructured":"Erro R, Pappat\u00e0 S, Amboni M, Vicidomini C, Longo K, Santangelo G, et al. Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson\u2019s disease patients. Parkinsonism Relat Disord. Elsevier. 2012;18:1034\u20138.","journal-title":"Parkinsonism & Related Disorders"},{"issue":"5","key":"907_CR68","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2169\/internalmedicine.52.8617","volume":"52","author":"Toshiyuki Yamanishi","year":"2013","unstructured":"Yamanishi T, Tachibana H, Oguru M, Matsui K, Toda K, Okuda B, et al. Anxiety and depression in patients with Parkinson\u2019s disease. Intern Med. The Japanese Society of Internal Medicine. 2013;52:539\u201345.","journal-title":"Internal Medicine"},{"key":"907_CR69","doi-asserted-by":"crossref","unstructured":"Vriend C, Boedhoe PS, Rutten S, Berendse HW, van der Werf YD, van den Heuvel OA. A smaller amygdala is associated with anxiety in Parkinson\u2019s disease: a combined FreeSurfer\u2014VBM study. J Neurol Neurosurg Psychiatry. 2016.","DOI":"10.1136\/jnnp-2015-310383"},{"key":"907_CR70","doi-asserted-by":"crossref","unstructured":"Oosterwijk CS, Vriend C, Berendse HW, van der Werf YD, van den Heuvel OA. Anxiety in Parkinson\u2019s disease is associated with reduced structural covariance of the striatum. J Affect Disord. Elsevier. 2018.","DOI":"10.1016\/j.jad.2018.07.053"},{"issue":"3","key":"907_CR71","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/mds.25748","volume":"29","author":"Michele T. M. Hu","year":"2014","unstructured":"Hu M, Szewczyk-Kr\u00f3likowski K, Tomlinson P, Nithi K, Rolinski M, Murray C, et al. Predictors of cognitive impairment in an early stage Parkinson\u2019s disease cohort. Mov Disord. Wiley Online Library. 2014;29:351\u20139.","journal-title":"Movement Disorders"},{"issue":"2","key":"907_CR72","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1076\/anec.9.2.77.9543","volume":"9","author":"Katherine A. Ryder","year":"2002","unstructured":"Ryder KA, Gontkovsky ST, McSwan KL, Scott JG, Bharucha KJ, Beatty WW. Cognitive function in Parkinson\u2019s disease: association with anxiety but not depression. Aging Neuropsychol Cognit. 2002;9(2), 77-84.","journal-title":"Aging, Neuropsychology, and Cognition"},{"issue":"3-4","key":"907_CR73","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000345987","volume":"35","author":"Chaorui Huang","year":"2013","unstructured":"Huang C, Ravdin LD, Nirenberg MJ, Piboolnurak P, Severt L, Maniscalco JS, et al. Neuroimaging markers of motor and nonmotor features of Parkinson\u2019s disease: an 18f fluorodeoxyglucose positron emission computed tomography study. Dement Geriatr Cogn Disord. 2013;35(3-4):183-196","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"907_CR74","unstructured":"Grant JE, Schreiber L, Odlaug BL. Impulse control disorders: updated review of clinical characteristics and pharmacological management. Front Psychiatry. Frontiers. 2011;2:1."},{"key":"907_CR75","unstructured":"Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. American Medical Association. 2010;67:589\u201395."},{"issue":"12","key":"907_CR76","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/mds.21072","volume":"21","author":"Maurizio Avanzi","year":"2006","unstructured":"Avanzi M, Baratti M, Cabrini S, Uber E, Brighetti G, Bonf\u00e0 F. Prevalence of pathological gambling in patients with Parkinson\u2019s disease. Mov Disord. Wiley Online Library. 2006;21:2068\u201372.","journal-title":"Movement Disorders"},{"issue":"7","key":"907_CR77","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/01.wnl.0000238503.20816.13","volume":"67","author":"V. Voon","year":"2006","unstructured":"Voon V, Hassan K, Zurowski M, De Souza M, Thomsen T, Fox S, et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology. AAN Enterprises. 2006;67:1254\u20137.","journal-title":"Neurology"},{"issue":"2","key":"907_CR78","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mds.26016","volume":"30","author":"D Weintraub","year":"2015","unstructured":"Weintraub D, David AS, Evans AH, Grant JE, Stacy M. Clinical spectrum of impulse control disorders in Parkinson\u2019s disease. Mov Disord. 2015;30(2):121\u20137.","journal-title":"Mov Disord"},{"issue":"11","key":"907_CR79","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/mds.23147","volume":"25","author":"Hengyi Rao","year":"2010","unstructured":"Rao H, Mamikonyan E, Detre JA, Siderowf AD, Stern MB, Potenza MN, et al. Decreased ventral striatal activity with impulse control disorders in Parkinson\u2019s disease. Mov Disord. Wiley Online Library. 2010;25:1660\u20139.","journal-title":"Movement Disorders"},{"issue":"1","key":"907_CR80","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.nbd.2010.03.013","volume":"39","author":"Roberto Cilia","year":"2010","unstructured":"Cilia R, Ko JH, Cho SS, van Eimeren T, Marotta G, Pellecchia G, et al. Reduced dopamine transporter density in the ventral striatum of patients with Parkinson\u2019s disease and pathological gambling. Neurobiol Dis. Elsevier. 2010;39:98\u2013104.","journal-title":"Neurobiology of Disease"},{"issue":"6","key":"907_CR81","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/mds.22472","volume":"24","author":"Gabriella Santangelo","year":"2009","unstructured":"Santangelo G, Vitale C, Trojano L, Verde F, Grossi D, Barone P. Cognitive dysfunctions and pathological gambling in patients with Parkinson\u2019s disease. Mov Disord. Wiley Online Library. 2009;24:899\u2013905.","journal-title":"Movement Disorders"},{"issue":"2","key":"907_CR82","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nn1378","volume":"8","author":"Jan Reuter","year":"2005","unstructured":"Reuter J, Raedler T, Rose M, Hand I, Gl\u00e4scher J, B\u00fcchel C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci. Nature Publishing Group. 2005;8:147.","journal-title":"Nature Neuroscience"},{"issue":"5","key":"907_CR83","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/mds.26160","volume":"30","author":"C Siri","year":"2015","unstructured":"\u2022 Siri C, Cilia R, Reali E, Pozzi B, Cereda E, Colombo A, et al. Long-term cognitive follow-up of Parkinson\u2019s disease patients with impulse control disorders. Mov Disord. 2015;30(5):696\u2013704 The first study to assess cognitive decline in patients with Parkinson\u2019s disease with impulse control disorders.","journal-title":"Mov Disord"},{"issue":"2","key":"907_CR84","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00415-009-5301-5","volume":"257","author":"Chiara Siri","year":"2009","unstructured":"Siri C, Cilia R, De Gaspari D, Canesi M, Meucci N, Zecchinelli AL, et al. Cognitive status of patients with Parkinson\u2019s disease and pathological gambling. J Neurol. Springer. 2010;257:247\u201352.","journal-title":"Journal of Neurology"},{"issue":"1","key":"907_CR85","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1467-9450.2010.00837.x","volume":"52","author":"J Linnet","year":"2011","unstructured":"Linnet J, Moller A, Peterson E, Gjedde A, Doudet D. Inverse association between dopaminergic neurotransmission and Iowa Gambling Task performance in pathological gamblers and healthy controls. Scand J Psychol. 2011;52(1):28\u201334.","journal-title":"Scand J Psychol"},{"key":"907_CR86","unstructured":"Steeves TDL, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T, et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain. Oxford University Press. 2009;132:1376\u201385."},{"issue":"2","key":"907_CR87","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/brain\/111.2.299","volume":"111","author":"A.M. GOTHAM","year":"1988","unstructured":"Gotham AM, Brown RG, Marsden CD. \u201cFrontal\u201d cognitive function in patients with Parkinson\u2019s disease \u201con\u201d and \u201coff\u201d levodopa. Brain. 1988;111 (Pt 2):299-321","journal-title":"Brain"},{"key":"907_CR88","doi-asserted-by":"crossref","unstructured":"Corvol J-C, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, et al. Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology. AAN Enterprises. 2018;10\u20131212.","DOI":"10.1212\/WNL.0000000000005816"},{"issue":"6","key":"907_CR89","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/mds.24939","volume":"27","author":"Ronald B. Postuma","year":"2012","unstructured":"Postuma RB, Bertrand J, Montplaisir J, Desjardins C, Vendette M, Rios Romenets S, et al. Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson\u2019s disease: a prospective study. Mov Disord. Wiley Online Library. 2012;27:720\u20136.","journal-title":"Movement Disorders"},{"issue":"4","key":"907_CR90","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.22691","volume":"71","author":"V Kotagal","year":"2012","unstructured":"Kotagal V, Albin RL, Muller MLTM, Koeppe RA, Chervin RD, Frey KA, et al. Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Ann Neurol. 2012;71(4):560\u20138.","journal-title":"Ann Neurol"},{"issue":"1","key":"907_CR91","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ana.21680","volume":"66","author":"Jean-Fran\u00e7ois Gagnon","year":"2009","unstructured":"Gagnon J, Vendette M, Postuma RB, Desjardins C, Massicotte-Marquez J, Panisset M, et al. Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson\u2019s disease. Ann Neurol Off J Am Neurol Assoc Child Neurol Soc. Wiley Online Library. 2009;66:39\u201347.","journal-title":"Annals of Neurology"},{"issue":"4","key":"907_CR92","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1212\/WNL.59.4.585","volume":"59","author":"J.- F. Gagnon","year":"2002","unstructured":"Gagnon J-F, B\u00e9dard M-A, Fantini ML, Petit D, Panisset M, Rompre S, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson\u2019s disease. Neurology. AAN Enterprises. 2002;59:585\u20139.","journal-title":"Neurology"},{"issue":"19","key":"907_CR93","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1212\/01.wnl.0000278114.14096.74","volume":"69","author":"M. Vendette","year":"2007","unstructured":"Vendette M, Gagnon J-F, Decary A, Massicotte-Marquez J, Postuma RB, Doyon J, et al. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology. AAN Enterprises. 2007;69:1843\u20139.","journal-title":"Neurology"},{"key":"907_CR94","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.parkreldis.2015.11.027","volume":"23","author":"Jae-Sung Lim","year":"2016","unstructured":"Lim J-S, Shin SA, Lee J-Y, Nam H, Lee J-Y, Kim YK. Neural substrates of rapid eye movement sleep behavior disorder in Parkinson\u2019s disease. Parkinsonism Relat Disord. Elsevier. 2016;23:31\u20136.","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"907_CR95","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neulet.2012.04.029","volume":"518","author":"William D.S. Killgore","year":"2012","unstructured":"Killgore WDS, Schwab ZJ, Kipman M, DelDonno SR, Weber M. Voxel-based morphometric gray matter correlates of daytime sleepiness. Neurosci Lett. Elsevier. 2012;518:10\u20133.","journal-title":"Neuroscience Letters"},{"key":"907_CR96","unstructured":"Garc\u00eda-Lorenzo D, Longo-Dos Santos C, Ewenczyk C, Leu-Semenescu S, Gallea C, Quattrocchi G, et al. The coeruleus\/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson\u2019s disease. Brain. Oxford University Press. 2013;136:2120\u20139."},{"key":"907_CR97","doi-asserted-by":"crossref","unstructured":"Siderowf A, Stern MB. Premotor Parkinson\u2019s disease: clinical features, detection, and prospects for treatment. Ann Neurol. Wiley Online Library. 2008;64.","DOI":"10.1002\/ana.21462"},{"issue":"15","key":"907_CR98","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1212\/01.wnl.0000340980.19702.6e","volume":"72","author":"RB Postuma","year":"2009","unstructured":"Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, Montplaisir J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology. 2009;72(15):1296\u2013300.","journal-title":"Neurology"},{"key":"907_CR99","doi-asserted-by":"crossref","unstructured":"Kehagia AA, Barker RA, Robbins TW. Cognitive impairment in Parkinson\u2019s disease: the dual syndrome hypothesis. Neurodegener Dis. 2012.","DOI":"10.1159\/000341998"},{"key":"907_CR100","doi-asserted-by":"crossref","unstructured":"Jellinger KA. Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study. Neuropsychiatr Disord An Integr Approach. Springer. 2007;91\u2013104.","DOI":"10.1007\/978-3-211-73574-9_12"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-018-0907-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-018-0907-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-018-0907-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T10:10:34Z","timestamp":1720692634000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-018-0907-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":100,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["907"],"URL":"https:\/\/doi.org\/10.1007\/s11910-018-0907-6","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]},"assertion":[{"value":"15 October 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Alexandru Hanganu and Oury Monchi each declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Information Consent"}}],"article-number":"91"}}